Last Updated

23 Jul 2020

Myanmar Malaria Indicator Survey


This Malaria Indicator Survey project in Myanmar aimed to provide national baseline data on malaria intervention coverage, malaria prevalence, population awareness and availability of malaria services in a representative sample of the population.

Primary objective: Determine the prevalence of malaria parasitemia (through PCR) among at-risk populations according to agreed risk strata.

Secondary objectives:

  1. Measure access, coverage and use of key malaria control and prevention interventions (including long lasting insecticidal nets, diagnostics, and treatment).
  2. Measure the knowledge, attitudes, and practices of key target populations with regard to malaria prevention and control.
  3. Compare and investigate malaria risk factors across additional malaria diagnostic tools and other transmission metrics (e.g. malaria rapid diagnostic tests and serology).
  4. Provide information on core indicators for the NMCP and other key stakeholders to measure progress against the existing baseline.
Rationale and Abstract

The significant reduction of malaria morbidity and mortality in Myanmar is threatened by a number of factors. The largest of these threats is the emergence of drug-resistant malaria parasites along the international border areas, including the Myanmar-Thailand and Myanmar-China borders as well as in some areas in central Myanmar.

However, to date, no malaria surveys have been conducted at national scale to assess coverage of key malaria indicators. Although efforts are being made to improve the health information system in Myanmar, malaria data remain incomplete with regards to geographical coverage (past surveys did not fully capture hard-to-access areas), completeness, and coverage of high-risk groups.

To respond to this need, the National Malaria Control Programme will lead in conducting a national malaria indicator survey in 2015 with Malaria Consortium as the technical lead and funding support from the President’s Malaria Initiative, the US Centers for Disease Control and Prevention, the Three Millennium Development Goal Fund (3MDG), GFATM and other partners.

The results of this survey will help to prioritise malaria services more effectively to areas of greatest malaria burden and provide baseline malaria data to support future assessments of the impact of all malaria-related activities nationwide, as well as for future strategic planning. Additionally, it is hoped that the malaria survey will provide up-to-date information on malaria prevalence within each area of the country, enabling the Ministry of Health to determine if its current risk stratification is still reliable.